Genetic and Neutralization Properties of HIV-1 env Clones From Subtype B/BC/AE Infections in China

Journal of acquired immune deficiency syndromes (1999) - Tập 47 Số 5 - Trang 535-543 - 2008
Huihui Chong1, Kunxue Hong, Chuntao Zhang, Jianhui Nie, Aijing Song, Wei Kong, Youchun Wang
1College of Life Science, Jilin University, Changchun, China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Letvin, 2002, Prospects for vaccine protection against HIV-1 infection and AIDS., Annu Rev Immunol, 20, 73, 10.1146/annurev.immunol.20.081501.094854

Mascola, 2003, Defining the protective antibody response for HIV-1., Curr Mol Med, 3, 209, 10.2174/1566524033479799

Parren, 1999, The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity., AIDS, 13, S137

Kwong, 1998, Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody., Nature, 393, 648, 10.1038/31405

Peut, 2006, Fitness constraints on immune escape from HIV: implications of envelope as a target for both HIV-specific T cells and antibody., Curr HIV Res, 4, 191, 10.2174/157016206776055110

Gray, 2006, Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B., PLoS Med, 3, e255, 10.1371/journal.pmed.0030255

Li, 2005, Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies., J Virol, 79, 10108, 10.1128/JVI.79.16.10108-10125.2005

Li, 2006, Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa., J Virol, 80, 11776, 10.1128/JVI.01730-06

Blish, 2007, HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry., AIDS, 21, 693, 10.1097/QAD.0b013e32805e8727

Wang, 2008, The impact of HIV-1 genetic diversity in China on the measurement of viral load., J Med Virol, 80, 1, 10.1002/jmv.21048

Platt, 1998, Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1., J Virol, 72, 2855, 10.1128/JVI.72.4.2855-2864.1998

Wei, 2002, Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy., Antimicrob Agents Chemother, 46, 1896, 10.1128/AAC.46.6.1896-1905.2002

Wei, 2003, Antibody neutralization and escape by HIV-1., Nature, 422, 307, 10.1038/nature01470

Derdeyn, 2004, Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission., Science, 303, 2019, 10.1126/science.1093137

Gray, 2007, Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection., J Virol, 81, 6187, 10.1128/JVI.00239-07

Burton, 1997, The antibody response in HIV-1 infection., AIDS, 11, S87

Kessler, 1997, Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates., AIDS Res Hum Retroviruses, 13, 575, 10.1089/aid.1997.13.575

Sanders, 2002, The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120., J Virol, 76, 7293, 10.1128/JVI.76.14.7293-7305.2002

Burton, 1994, Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody., Science, 266, 1024, 10.1126/science.7973652

Mo, 1997, Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. off., J Virol, 71, 6869, 10.1128/JVI.71.9.6869-6874.1997

Parker, 2001, Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5., J Virol, 75, 10906, 10.1128/JVI.75.22.10906-10911.2001

Binley, 2004, Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies., J Virol, 78, 13232, 10.1128/JVI.78.23.13232-13252.2004

Buchacher, 1994, Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization., AIDS Res Hum Retroviruses, 10, 359, 10.1089/aid.1994.10.359

Kunert, 1998, Molecular characterization of five neutralizing anti-HIV type 1 antibodies: identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5., AIDS Res Hum Retroviruses, 14, 1115, 10.1089/aid.1998.14.1115

Scanlan, 2002, The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha12 mannose residues on the outer face of gp120., J Virol, 76, 7306, 10.1128/JVI.76.14.7306-7321.2002

Calarese, 2003, Antibody domain exchange is an immunological solution to carbohydrate cluster recognition., Science, 300, 2065, 10.1126/science.1083182

Muster, 1993, A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1., J Virol, 67, 6642, 10.1128/JVI.67.11.6642-6647.1993

Zwick, 2001, Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41., J Virol, 75, 10892, 10.1128/JVI.75.22.10892-10905.2001